373 related articles for article (PubMed ID: 17418457)
21. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18.
Liu Q; Shang L; Jin H; Wei F; Zhu XQ; Gao H
Res Vet Sci; 2010 Aug; 89(1):93-7. PubMed ID: 20132954
[TBL] [Abstract][Full Text] [Related]
22. Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis.
Gatkowska J; Gasior A; Kur J; Dlugonska H
Exp Parasitol; 2008 Feb; 118(2):266-70. PubMed ID: 17825290
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy.
Min J; Qu D; Li C; Song X; Zhao Q; Li XA; Yang Y; Liu Q; He S; Zhou H
Vaccine; 2012 Aug; 30(38):5631-6. PubMed ID: 22789504
[TBL] [Abstract][Full Text] [Related]
24. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.
Chuang SC; Ko JC; Chen CP; Du JT; Yang CD
Parasit Vectors; 2013 Feb; 6():34. PubMed ID: 23398973
[TBL] [Abstract][Full Text] [Related]
25. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
[TBL] [Abstract][Full Text] [Related]
26. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
Chen G; Chen H; Guo H; Zheng H
Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
[TBL] [Abstract][Full Text] [Related]
29. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Yang X; Huang S; Chen J; Song N; Wang L; Zhang Z; Deng G; Zheng H; Zhu XQ; Lu F
Vaccine; 2010 Jan; 28(3):737-43. PubMed ID: 19887128
[TBL] [Abstract][Full Text] [Related]
31. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
[TBL] [Abstract][Full Text] [Related]
32. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
Jongert E; de Craeye S; Dewit J; Huygen K
Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
[TBL] [Abstract][Full Text] [Related]
34. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
[TBL] [Abstract][Full Text] [Related]
35. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
[TBL] [Abstract][Full Text] [Related]
36. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
Zhang G; Huong VT; Battur B; Zhou J; Zhang H; Liao M; Kawase O; Lee EG; Dautu G; Igarashi M; Nishikawa Y; Xuan X
Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
[TBL] [Abstract][Full Text] [Related]
37. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
[TBL] [Abstract][Full Text] [Related]
38. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
